论文信息 - ISB 1342: A first-in-class CD38 T cell engager for the treatment of relapsed refractory multiple myeloma. - 字舞流文

ISB 1342: A first-in-class CD38 T cell engager for the treatment of relapsed refractory multiple myeloma.

M. Perro | M. Doucey | Adam Drake | T. Monney | Riccardo Turrini | C. Stutz | S. Blein | A. Croset | Amélie Laurendon | M. Mbow | J. Macoin | Blandine Pouleau | C. Estoppey | M. Pluess | Christelle Ries-Fecourt | Perrine Suere | Emilie Nallet